Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARHGEF6 |
| Upstream (Parents) |
|---|
| (<<) HEG1 → ARHGEF6 |
| (<<) IL10RA → ARHGEF6 |
| (<<) EVL → ARHGEF6 |
| (<<) RFTN1 → ARHGEF6 |
| Downstream (Children) |
|---|
| ARHGEF6 → BTNL8 (>>) |
| ARHGEF6 → SP2 (>>) |
| ARHGEF6 → LY9 (>>) |
| ARHGEF6 → FHL1 (>>) |
| ARHGEF6 → CEP152 (>>) |
| ARHGEF6 → CLDN5 (>>) |
| ARHGEF6 → ITGA4 (>>) |
| ARHGEF6 → LOC390940 (>>) |
| ARHGEF6 → AOC3 (>>) |
| ARHGEF6 → IL10RA (>>) |
| ARHGEF6 → MDFIC (>>) |
| ARHGEF6 → LYST (>>) |
| ARHGEF6 → CSH1 (>>) |
| ARHGEF6 → MLLT10 (>>) |
| ARHGEF6 → SDC3 (>>) |
| ARHGEF6 → C14orf139 (>>) |
| ARHGEF6 → LILRA6 (>>) |
